Status:
RECRUITING
A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Panic Disorder With Agoraphobia
Panic Disorder Without Agoraphobia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The project's aim is to investigate the effect of a transdiagnostic, self-guided, internet-based cognitive behavioral therapy program in waitlist patients with anxiety disorders.
Detailed Description
Patients who fulfill the inclusion criteria and are interested in psychotherapy are offered participation in the study to bridge the waiting time for face-to-face psychotherapy. After obtaining inform...
Eligibility Criteria
Inclusion
- Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder
- Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires
- Written informed consent
- Internet access
Exclusion
- Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder)
- Acute suicidality
- Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)
Key Trial Info
Start Date :
July 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04793828
Start Date
July 4 2020
End Date
December 31 2025
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin
Berlin, Germany, 10117